This application requests funding for the Tulane National Primate Research Center (TNPRC) for the fiveyear period beginning May 1, 2008 through April 30, 2013. Funds will be used to support the administration, operations, veterinary resources, scientific research resources and education and training mission of the Center. Additional funds to support pilot research projects and colony-health-related research resource projects are also requested. For nearly three decades the main focus of the TNPRC research program has been infectious disease. This will continue. In addition, a significant program in gene therapy that is tightly linked to the Center for Gene Therapy at Tulane has developed over the last five years. The major areas of funding for the infectious disease program are currently AIDS, Lyme disease and biodefense-related agents;there are also areas under development, such as tuberculosis. These are multidisciplinary studies involving investigators in multiple Divisions at the TNPRC and collaborators outside the Center. The studies cover the spectrum from transmission and pathogenesis to development of vaccine strategies and chemotherapeutic treatments. The gene therapy program provides an important link to the rest of the University, allows for novel approaches to the treatment of many types of disease and imparts additional diversity to our research program. The period since the last submission of the TNPRC base grant has been a time of significant growth and improvement at the Center. Total sponsored funding has increased dramatically and individual, investigator initiated awards now exceed total awards at the time of the last base grant submission. We are currently at the beginning of a major expansion of our facilities in support of the growing research program. The total construction budget for current projects is in excess of $50M and will add approximately 80,000sf to the facility. The expansion is funded by numerous NIH construction awards (C06, UC6) and private funds. Of particular note is the Regional Biosafety Laboratory. This is a BSL-3 facility that will focus on biodefense and emerging infections in support of the NIH biodefense research agenda. Based on the progress in the last five years we are very optimistic about the future. Strengths on which we can capitalize include significant funded renovation and expansion projects, a research focus (infectious diseases and gene therapy) that matches NIH and national priorities, faculty appointments, strong and diverse research resources, a talented and dedicated staff, excellent interactions and collaborations with area universities and an outstanding relationship with our host institution and state and federal legislators.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Primate Research Center Grants (P51)
Project #
8P51OD011104-51
Application #
8296351
Study Section
Special Emphasis Panel (ZRR1-CM-8 (01))
Program Officer
Harding, John D
Project Start
1997-05-09
Project End
2013-06-17
Budget Start
2012-05-01
Budget End
2013-06-17
Support Year
51
Fiscal Year
2012
Total Cost
$7,901,242
Indirect Cost
$778,539
Name
Tulane University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Alvarez, Xavier; Midkiff, Cecily; Kuroda, Marcelo J et al. (2014) Detecting the simian immunodeficiency virus reservoir as viral DNA and RNA in situ simultaneously as a model to monitor viral latency. AIDS Res Hum Retroviruses 30:205-6
Mohan, Mahesh; Chandra, Lawrance C; Torben, Workineh et al. (2014) miR-190b is markedly upregulated in the intestine in response to simian immunodeficiency virus replication and partly regulates myotubularin-related protein-6 expression. J Immunol 193:1301-13
Ling, Binhua; Piatak Jr, Michael; Rogers, Linda et al. (2014) Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques. PLoS One 9:e102795
Monjure, C J; Tatum, C D; Panganiban, A T et al. (2014) Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA. J Med Primatol 43:31-43
Snook, Eric R; Fisher-Perkins, Jeanne M; Sansing, Hope A et al. (2014) Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy. Am J Pathol 184:382-96
Roy, Chad J; Adams, A Paige; Wang, Eryu et al. (2014) Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. J Infect Dis 209:1891-9
Lee, Kim M; Chiu, Kevin B; Renner, Nicole A et al. (2014) Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS. J Neurovirol 20:474-84
Gautam, Uma S; Mehra, Smriti; Ahsan, Muhammad H et al. (2014) Role of TNF in the altered interaction of dormant Mycobacterium tuberculosis with host macrophages. PLoS One 9:e95220
McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar et al. (2014) The Mycobacterium tuberculosis Rv2745c plays an important role in responding to redox stress. PLoS One 9:e93604
Loganantharaj, Nisha; Nichols, Whitney A; Bagby, Gregory J et al. (2014) The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques. AIDS Res Hum Retroviruses 30:783-91

Showing the most recent 10 out of 40 publications